Navigation Links
RSB Spine, LLC, Announces Record Second-Quarter 2010 Revenue and Monthly Sales Milestone
Date:6/30/2010

CLEVELAND, June 30 /PRNewswire/ -- RSB Spine, LLC, a medical device company focused on developing unique modular fusion products for surgical treatment of degenerative disc disease, today announced a 50% sales increase for the second quarter of 2010 versus second quarter 2009, and a 27% increase sequentially. Additionally, the company reported record sales for the month of June.

RSB Spine Chief Executive Officer John A. Redmond said: "Our master distributor, Paradigm BioDevices, exceeded our expectations with a strong sales performance. We expect even stronger growth in the second half of the year as we expand our modular offering and provide additional implantation options."  

"The understanding of our platform's capabilities is becoming more widely appreciated by surgeons and distributors," said Mike O'Neill, President of Paradigm BioDevices. "This is allowing us to rapidly expand our customer base."

RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.


'/>"/>
SOURCE RSB Spine, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. RSB Spine, LLC, Announces FDA Clearance for Its InterPlate(TM) C-PS and L-PS Interbody Spacers
2. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
3. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
4. THE PLANNING SHOP international Announces Oncology Business Unit
5. Sirius Genomics Announces Appointment of Senior Director of Business Development
6. Dragon Pharma announces date of special meeting
7. 3SBio Inc. Announces Filing of Form 20-F With SEC
8. Aeterna Zentaris Announces Collaboration with Almac to Develop Therapy and Companion Diagnostic in Cancer
9. Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression
10. Stemedica Announces the Appointment of Dr. Csar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
11. Angiotech Pharmaceuticals Announces Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Chef Jodi ... wine scene. Making stops in several cities, she gained a number of delicious ... began in Stellenbosch, a town in South Africa’s Western Cape province. It is ...
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/23/2017)... and NEW YORK ... HIMSS, Lumeon , a leading digital health ... Telehealth), a provider of telemedicine and remote patient ... pathways for telemedicine reimbursements.  DN ... their patients, in real-time, extending consultations beyond a ...
(Date:2/23/2017)... Atlanta, it seems everyone has a chance to express their ... expressive and dynamic community unlike any other. The businesses that ... With their newest salon in ... on that tradition with a unique, fresh approach to head ... the newest of 13 nationwide locations, each of them well-situated ...
Breaking Biology Technology:
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):